WO2001011025A3 - Cristallisation et determination de la structure de la thymidylate kinase de staphylococcus aureus - Google Patents

Cristallisation et determination de la structure de la thymidylate kinase de staphylococcus aureus Download PDF

Info

Publication number
WO2001011025A3
WO2001011025A3 PCT/US2000/021425 US0021425W WO0111025A3 WO 2001011025 A3 WO2001011025 A3 WO 2001011025A3 US 0021425 W US0021425 W US 0021425W WO 0111025 A3 WO0111025 A3 WO 0111025A3
Authority
WO
WIPO (PCT)
Prior art keywords
staphylococcus aureus
crystallization
thymidylate kinase
structure determination
aureus thymidylate
Prior art date
Application number
PCT/US2000/021425
Other languages
English (en)
Other versions
WO2001011025A2 (fr
Inventor
Timothy E Benson
Original Assignee
Upjohn Co
Timothy E Benson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co, Timothy E Benson filed Critical Upjohn Co
Priority to CA002378010A priority Critical patent/CA2378010A1/fr
Priority to AU66227/00A priority patent/AU781654B2/en
Priority to EP00953850A priority patent/EP1200565A2/fr
Priority to JP2001515812A priority patent/JP2003517818A/ja
Publication of WO2001011025A2 publication Critical patent/WO2001011025A2/fr
Publication of WO2001011025A3 publication Critical patent/WO2001011025A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1229—Phosphotransferases with a phosphate group as acceptor (2.7.4)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)

Abstract

L'invention concerne une forme sans ligand de thymidylate kinase (TMK) de Staphylococcus aureus (S. aureus), qui a été cristallisée, la structure cristalline à rayons X tridimensionnelle ayant une résolution de 2,3 Å. La structure cristalline à rayons X s'utilise pour résoudre la structure d'autres molécules ou complexes moléculaires, et désigner des inhibiteurs de l'activité de la thymidylate kinase (TMK) de S. aureus.
PCT/US2000/021425 1999-08-04 2000-08-04 Cristallisation et determination de la structure de la thymidylate kinase de staphylococcus aureus WO2001011025A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002378010A CA2378010A1 (fr) 1999-08-04 2000-08-04 Cristallisation et determination de la structure de la thymidylate kinase de staphylococcus aureus
AU66227/00A AU781654B2 (en) 1999-08-04 2000-08-04 Crystallization and structure determination of staphylococcus aureus thymidylate kinase
EP00953850A EP1200565A2 (fr) 1999-08-04 2000-08-04 Cristallisation et determination de la structure de la thymidylate kinase de staphylococcus aureus
JP2001515812A JP2003517818A (ja) 1999-08-04 2000-08-04 スタフィロコッカス・アウレウスのチミジル酸キナーゼの結晶化および構造決定

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14711799P 1999-08-04 1999-08-04
US60/147,117 1999-08-04

Publications (2)

Publication Number Publication Date
WO2001011025A2 WO2001011025A2 (fr) 2001-02-15
WO2001011025A3 true WO2001011025A3 (fr) 2001-08-23

Family

ID=22520348

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/021425 WO2001011025A2 (fr) 1999-08-04 2000-08-04 Cristallisation et determination de la structure de la thymidylate kinase de staphylococcus aureus

Country Status (5)

Country Link
EP (1) EP1200565A2 (fr)
JP (1) JP2003517818A (fr)
AU (1) AU781654B2 (fr)
CA (1) CA2378010A1 (fr)
WO (1) WO2001011025A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005016237A2 (fr) * 2003-05-07 2005-02-24 Smithkline Beecham Corporation Methionine aminopeptidase et procedes d'utilisation
US8741614B2 (en) * 2010-11-02 2014-06-03 Probiodrug Ag Crystal structure of isoglutaminyl cyclase

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0786519A2 (fr) * 1996-01-05 1997-07-30 Human Genome Sciences, Inc. Polynucléotides et séquences de Staphylococcus aureus
WO2000012678A2 (fr) * 1998-09-01 2000-03-09 Human Genome Sciences, Inc. Genes de staphylococcus aureus et polypeptides associes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0786519A2 (fr) * 1996-01-05 1997-07-30 Human Genome Sciences, Inc. Polynucléotides et séquences de Staphylococcus aureus
WO2000012678A2 (fr) * 1998-09-01 2000-03-09 Human Genome Sciences, Inc. Genes de staphylococcus aureus et polypeptides associes

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
A LAVIE ET AL: "Crystal structure of yeast thymidylate kinase complexed with the bisubstrate inhibitor TP5A at 2.0 A resolution: implications for catalysis and AZT activation", BIOCHEMISTRY,AMERICAN CHEMICAL SOCIETY. EASTON, PA,US, vol. 37, 1998, pages 3677 - 3686, XP002111244, ISSN: 0006-2960 *
A LAVIE ET AL: "Structural basis for the efficient phosphorylation of 3'-azidothymidine monophosphate by E. coli thymidylate kinase", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA,NATIONAL ACADEMY OF SCIENCE. WASHINGTON,US, vol. 95, November 1998 (1998-11-01), pages 14045 - 14050, XP002111243, ISSN: 0027-8424 *
DE LA SIERRA I LI ET AL: "Crystallization and preliminary X-ray analysis of the thymidylate kinase from Mycobacterium tuberculosis.", ACTA CRYSTALLOGRAPHICA SECTION D BIOLOGICAL CRYSTALLOGRAPHY, vol. 56, no. 2, February 2000 (2000-02-01), pages 226 - 228, XP000982605, ISSN: 0907-4449 *
OSTERMANN NILS ET AL: "Insights into the phosphoryltransfer mechanism of human thymidylate kinase gained from crystal structures of enzyme complexes along the reaction coordinate.", STRUCTURE (LONDON), vol. 8, no. 6, 2000, pages 629 - 642, XP000982582, ISSN: 0969-2126 *

Also Published As

Publication number Publication date
AU6622700A (en) 2001-03-05
JP2003517818A (ja) 2003-06-03
WO2001011025A2 (fr) 2001-02-15
AU781654B2 (en) 2005-06-02
CA2378010A1 (fr) 2001-02-15
EP1200565A2 (fr) 2002-05-02

Similar Documents

Publication Publication Date Title
CA2155322A1 (fr) Forme acide cristallisee libre de ceftiofur
CA2148928A1 (fr) Derives pyridine pharmacologiquement actifs ainsi que leurs procedes de preparation
EP0976760A3 (fr) Oligopeptides ayant l'activité fongicide
CA2359440A1 (fr) Phenylphenanthridines a activite inhibitrice de pde iv
EP1277754B8 (fr) Derives d'imidazopyridine
IT1303249B1 (it) Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
CA2349330A1 (fr) Heterobicycliques contenant de l'azote utilises comme inhibiteurs du facteur xa
CA2297911A1 (fr) 6-phenylphenanthridines substitues
AU6194694A (en) Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments
CA2103845A1 (fr) 9-[(glycyle substitue)-amido]-6-demethyl-6-desoxytetracyclines
PL348451A1 (en) Glycopeptide derivatives and pharmaceutical compositions containing the same
AU3126600A (en) N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
WO2000071493A3 (fr) INHIBITEURS DU FACTEUR Xa
AU4930299A (en) Remedies for neuropathy containing as the active ingredient galectin-1 or its derivatives
CA2186269A1 (fr) Cicatrisation
DE69631609D1 (en) Tricyclische erythromycinderivate
DE69720666D1 (de) Kristalline pulverige Saccharide, ihre Herstellung und Verwendung
AU1058492A (en) Improvements in or relating to organic compounds
CA2324154A1 (fr) 6-(2-halo-4-alcoxyphenyl)-triazolopyrimidines fongicides
AU752953C (en) Adding pharmaceutically active compounds to substrates
WO2001039723A3 (fr) Composes triazospiro presentant une affinite pour le recepteur de la nociceptine
AU2289400A (en) 6-arylphenanthridines with pde-iv inhibiting activity
WO2001011025A3 (fr) Cristallisation et determination de la structure de la thymidylate kinase de staphylococcus aureus
AU5290199A (en) Erythromycin derivatives with antibiotic activity
AU2107700A (en) Phenanthridine-n-oxides with pde-iv inhibiting activity

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 66227/00

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2378010

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2000953850

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000953850

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000953850

Country of ref document: EP